Entity

Time filter

Source Type

Costa Mesa, CA, United States

Trademark
DaVinci Biosciences LLC | Date: 2009-04-22

Processed biological materials, namely, processed human-derived primary cells, progenitor cells, cell lines and cell-based products, namely, cell pellets, lysates, RNA and cDNA for scientific research.


Trademark
DaVinci Biosciences LLC | Date: 2009-05-11

Processed biological materials, namely, processed human-derived primary cells, progenitor cells, cell lines and cell-based products, namely, cell pellets, lysates, RNA and cDNA for scientific research. Custom research, development, and consultation in the field of cell-based services, namely, profiling cellular products and their derivatives and conducting assays and cultures.


Trademark
Davinci Biosciences LLC | Date: 2012-11-29

immune cells, namely, cells for medical or veterinary use; tissue cells, namely, cells for medical or veterinary use; biological tissues, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for medical or veterinary use; derivatives of the aforementioned goods, namely, vaccines, proteins, peptides, cytokines, chemokines, antibodies, DNA, RNA, growth factors, cell lysate, extracellular matrix, and conditioned media for medical or veterinary use; Prophylactic and therapeutic vaccines; immune cells for medical use; pharmaceutical preparations for stimulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and conditions; Biochemicals, namely, proteases for use in human therapeutics, namely, for the treatment of infectious, auto-immune, cell-proliferative, inflammatory, metabolic, cardiovascular, respiratory, neurological, and musculoskeletal disorders and diseases.


Trademark
Davinci Biosciences LLC | Date: 2012-11-29

immune cells, namely, cells for medical or veterinary use; tissue cells, namely, cells for medical or veterinary use; biological tissues, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for medical or veterinary use; derivatives of the aforementioned goods, namely, vaccines, proteins, peptides, cytokines, chemokines, antibodies, DNA, RNA, growth factors, cell lysate, extracellular matrix, and conditioned media for medical or veterinary use; Prophylactic and therapeutic vaccines; immune cells for medical use; pharmaceutical preparations for stimulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and conditions; Biochemicals, namely, proteases for use in human therapeutics, namely, for the treatment of infectious, auto-immune, cell-proliferative, inflammatory, metabolic, cardiovascular, respiratory, neurological, and musculoskeletal disorders and diseases.


Human umbilical cord lining stem cells that are capable of differentiating into cells of the mesodermal lineage and ectodermal lineage are described, as well as methods of isolating, expanding, culturing, and cryopreserving such cells.

Discover hidden collaborations